Profile data is unavailable for this security.
About the company
YABAO PHARMACEUTICAL GROUP CO. LTD is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals. The Company mainly provides light pastes, tablets, injections, capsules, oral liquids, bulk drugs and other pharmaceutical products. The Company is also engaged in the wholesaling and trading of pharmaceuticals. The Company distributes its products within domestic market and to overseas markets.
- Revenue in CNY (TTM)2.83bn
- Net income in CNY220.70m
- Incorporated1999
- Employees4.14k
- LocationYabao Pharmaceutical Group Co LtdNo.1Gongye BoulevardFenglingdu Economic Development ZoneBEIJING 100176ChinaCHN
- Phone+86 1 057809936
- Fax+86 1 057809937
- Websitehttp://www.yabao.com.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lionco Pharmaceutical Group Co Ltd | 277.20m | -101.80m | 4.33bn | 475.00 | -- | 5.06 | -- | 15.61 | -0.144 | -0.144 | 0.3828 | 1.19 | 0.1843 | 2.48 | 4.41 | 583,571.30 | -6.77 | 0.7396 | -7.85 | 0.9562 | 41.77 | 80.88 | -36.73 | 2.08 | 4.94 | -4.74 | 0.2409 | 521.93 | -31.95 | -34.79 | 22.65 | -- | -33.18 | -- |
| Chengdu Olymvax Biopharmaceuticals Inc | 530.47m | -8.70m | 4.34bn | 471.00 | -- | 4.77 | -- | 8.19 | -0.0219 | -0.0219 | 1.31 | 2.24 | 0.3301 | 0.3685 | 1.04 | 1,126,255.00 | -0.9143 | 3.17 | -1.28 | 4.68 | 94.19 | 93.00 | -2.77 | 7.44 | 1.67 | -0.5392 | 0.2915 | 9.82 | -9.38 | 45.40 | -33.94 | -- | 56.47 | -- |
| Tibet Weixinkang Pharmaceutical Co Ltd | 1.26bn | 247.04m | 4.35bn | 701.00 | 17.61 | 2.94 | -- | 3.47 | 0.5677 | 0.5677 | 2.89 | 3.41 | 0.6778 | 16.41 | 5.56 | 1,791,483.00 | 13.33 | 8.20 | 17.01 | 11.13 | 53.45 | 50.20 | 19.67 | 11.53 | 3.27 | -- | 0.0075 | 59.11 | -5.43 | 12.13 | 20.94 | 23.85 | -5.61 | 38.96 |
| Zhejiang Shouxiangu Pharmaceuticl Co Ltd | 713.75m | 233.79m | 4.40bn | 1.14k | 18.59 | 1.97 | -- | 6.16 | 1.19 | 1.19 | 3.63 | 11.26 | 0.2367 | 0.7194 | 7.25 | 624,455.80 | 7.75 | 10.04 | 9.09 | 11.63 | 80.01 | 83.66 | 32.75 | 28.29 | 3.48 | -- | 0.2098 | 47.86 | -5.39 | 8.93 | -8.39 | 18.78 | 12.23 | 17.13 |
| Zhejiang Starry Pharmaceutical Co Ltd | 2.37bn | 13.89m | 4.45bn | 1.85k | 202.11 | 1.67 | -- | 1.88 | 0.0502 | 0.0502 | 5.72 | 6.08 | 0.4094 | 1.74 | 6.76 | 1,284,337.00 | 0.2471 | 3.30 | 0.4806 | 5.97 | 21.35 | 32.35 | 0.6036 | 8.21 | 0.4855 | 1.21 | 0.4994 | 53.08 | 3.04 | 19.78 | 158.32 | -13.94 | 10.39 | -- |
| Shanghai New World Co Ltd | 1.13bn | 45.48m | 4.55bn | 1.20k | 100.00 | 1.08 | -- | 4.01 | 0.0703 | 0.0703 | 1.75 | 6.53 | 0.201 | 3.94 | 10.25 | 942,735.10 | 0.7905 | 0.5242 | 1.05 | 0.7249 | 38.77 | 33.70 | 3.93 | 2.71 | 1.57 | -- | 0.1158 | 82.75 | 33.39 | -16.40 | 160.85 | -35.00 | 53.61 | -25.42 |
| Yabao Pharmaceutical Group Co Ltd | 2.83bn | 220.70m | 4.56bn | 4.14k | 20.71 | 1.54 | -- | 1.61 | 0.3057 | 0.3057 | 3.86 | 4.10 | 0.7389 | 3.51 | 6.66 | 683,686.80 | 5.11 | 2.82 | 6.38 | 3.97 | 52.85 | 59.20 | 6.92 | 4.19 | 2.04 | 129.51 | 0.0313 | 43.74 | 7.05 | -0.0572 | 90.71 | -6.10 | 7.98 | -9.71 |
| Pulike Biological Engineering Inc | 1.09bn | 101.68m | 4.62bn | 1.68k | 45.08 | 1.73 | -- | 4.25 | 0.296 | 0.296 | 3.13 | 7.72 | 0.3373 | 2.48 | 2.65 | 646,748.50 | 3.16 | 7.64 | 3.73 | 8.96 | 60.45 | 62.57 | 9.36 | 17.85 | 2.51 | -- | 0.0086 | 52.48 | 1.84 | 15.55 | 3.99 | 5.17 | 41.58 | 18.47 |
Data as of Nov 22 2024. Currency figures normalised to Yabao Pharmaceutical Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
1.19%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Universal Asset Management Co., Ltd.as of 30 Jun 2024 | 3.14m | 0.41% |
| The Vanguard Group, Inc.as of 30 Sep 2024 | 2.83m | 0.37% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2024 | 1.13m | 0.15% |
| Wanjia Asset Management Co., Ltd.as of 30 Jun 2024 | 561.40k | 0.07% |
| Acadian Asset Management LLCas of 30 Sep 2024 | 360.00k | 0.05% |
| Everbright Securities Asset Management Co., Ltd.as of 30 Jun 2024 | 336.00k | 0.04% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2024 | 291.30k | 0.04% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 160.50k | 0.02% |
| Hongde Fund Management Co., Ltd.as of 30 Jun 2024 | 157.60k | 0.02% |
| Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2024 | 150.40k | 0.02% |
More ▼
Data from 30 Jun 2024 - 11 Nov 2024Source: FactSet Research Systems Inc.
